Published in Adv Cardiol on January 01, 1974
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol (1985) 1.65
Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine. Br J Clin Pharmacol (1983) 1.19
Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction. Br Med J (Clin Res Ed) (1981) 1.19
In vitro activity of RO363, a beta1-adrenoceptor selective agonist. Br J Pharmacol (1980) 1.07
Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists. Br J Clin Pharmacol (1984) 1.03
Effects of beta-adrenoreceptor blocking drugs on adrenergic transmission. Drugs (1976) 0.97
The functional significance of genetic variation within the beta-adrenoceptor. Br J Clin Pharmacol (2005) 0.93
The beta 1- and beta 2-adrenoceptor affinity and beta 1-blocking potency of S- and R-metoprolol. Br J Pharmacol (1990) 0.83
Some aspects of the pharmacology of beta-adrenorecptor blockers. Drugs (1976) 0.83
Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses. Br J Pharmacol (1994) 0.79
Comparison of pharmacological and binding assays for ten beta-adrenoceptor blocking agents and two beta-adrenoceptor agonists. Br J Pharmacol (1980) 0.76
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 9.57
The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet (1999) 6.23
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists. Life Sci I (1973) 2.83
Antibody-forming cells in human colostrum after oral immunisation. Nature (1975) 2.76
Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol (1998) 2.55
Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1986) 2.46
The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol (1999) 2.37
Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A (2001) 2.35
Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1977) 2.26
Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with T cell receptor beta chain gene alleles or haplotypes. Arthritis Rheum (1991) 2.20
Toxicological studies on omeprazole. Scand J Gastroenterol Suppl (1985) 2.19
Headache recurrence after subcutaneous sumatriptan and early treatment. Lancet (1992) 2.08
Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation (1979) 2.08
A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) (1975) 2.01
Ochratoxin A as the cause of spontaneous nephropathy in fattening pigs. Appl Environ Microbiol (1978) 1.86
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med (2008) 1.81
Protective factors in milk and the development of the immune system. Pediatrics (1985) 1.73
Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist. Acta Pharmacol Toxicol (Copenh) (1967) 1.65
Peste des petits ruminants (PPR) outbreak in Tajikistan. J Comp Pathol (2007) 1.61
Metabolism of metoprolol-(3-h) in man, the dog and the rat. Acta Pharmacol Toxicol (Copenh) (1975) 1.61
Left ventricular filling and diastolic pressure-volume relations in the conscious dog. Circ Res (1969) 1.60
Trial of a method of reducing inappropriate demands on a hospital emergency department. Public Health (1987) 1.59
Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG (2006) 1.54
Ergotamine in the acute treatment of migraine: a review and European consensus. Brain (2000) 1.52
A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res (2000) 1.52
Antibody production by human colostral cells. I. Immunoglobulin class, specificity, and quantity. Scand J Immunol (1975) 1.43
P450/losec. Gastroenterology (1991) 1.40
Backscatter radiation at tissue-titanium interfaces. Analyses of biological effects from 60Co and protons. Acta Oncol (1991) 1.39
[Ritual circumcision of small boys is barbaric]. Lakartidningen (1998) 1.38
[A vicious circle when headache medication is the cause of chronic headache. A well-planned ambulatory detoxication can result in dramatic improvement]. Lakartidningen (2001) 1.38
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet (1997) 1.36
Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol (1999) 1.34
Local antibodies in childhood urinary tract infection: a preliminary study. Int Arch Allergy Appl Immunol (1974) 1.33
A sensitive method for specific quantitation of secretory IgA. Scand J Immunol (1977) 1.29
Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes (Lond) (2010) 1.27
Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology (1990) 1.23
Expression of a novel member of estrogen response element-binding nuclear receptors is restricted to the early stages of chorion formation during mouse embryogenesis. Mech Dev (1996) 1.23
Recurrent abdominal pains as the first symptom of a spinal cord tumor. Acta Paediatr Scand (1981) 1.23
beta-Adrenoceptor blockers, plasma-potassium, and exercise. Lancet (1978) 1.22
Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab (1998) 1.22
Secretory IgA and IgM antibodies to E. coli O and poliovirus type I antigens occur in amniotic fluid, meconium and saliva from newborns. A neonatal immune response without antigenic exposure: a result of anti-idiotypic induction? Clin Exp Immunol (1986) 1.22
Stoma-related complications and stoma size - a 2-year follow up. Colorectal Dis (2010) 1.21
Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology (1983) 1.18
High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. Epidemiol Infect (1998) 1.18
The urgency of care need and patient satisfaction at a hospital emergency department. Health Care Manage Rev (1992) 1.18
Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab (1997) 1.18
Inadequacy of mucosal IgM antibodies in selective IgA deficiency: excretion of attenuated polio viruses is prolonged. J Clin Immunol (1988) 1.17
Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants. Acta Paediatr Scand (1991) 1.16
Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril (1993) 1.16
Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden. Cephalalgia (2004) 1.15
Conformational transitions of polynucleotides in polymer media. Eur J Biochem (1974) 1.14
Constitutional downregulation of SEMA5A expression in autism. Neuropsychobiology (2006) 1.13
Hepatic-artery ligation for hepatic hemangiomatosis. N Engl J Med (1967) 1.12
Prevalence of perceived symptoms of dry mouth in an adult Swedish population--relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol (1997) 1.12
Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol (1986) 1.11
Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab (2000) 1.11
Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination. J Infect Dis (1985) 1.11
Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13. J Med Genet (2004) 1.10
IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5. Genes Immun (2007) 1.09
An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis. APMIS (2002) 1.08
Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1988) 1.08
Influence of maternal gut flora and colostral and cord serum antibodies on presence of Escherichia coli in faeces of the newborn infant. Acta Paediatr Scand (1976) 1.07
Studies on beta-adrenoceptor mediated facilitation of sympathetic neurotransmission. Acta Physiol Scand Suppl (1981) 1.04
Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines. Regul Pept (1986) 1.03
Secretory antibodies in IgA-deficient and immunosuppressed individuals. J Clin Immunol (1986) 1.02
Audiovestibular and neuropsychological outcome of adults who had recovered from childhood bacterial meningitis. Int J Pediatr Otorhinolaryngol (1997) 1.02
Studies of Escherichia coli O antigen specific antibodies in human milk, maternal serum and cord blood. Acta Paediatr Scand (1976) 1.02
Site of increased vascular resistance during isometric muscle contraction. Am J Physiol (1967) 1.02
Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery. Acta Physiol Scand (1985) 1.02
The role of beta-1-adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation. Pflugers Arch (1980) 1.01
Determination of left ventricular volume in children: echocardiographic and angiographic comparisons. Circulation (1980) 1.01
Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk. Acta Diabetol (2008) 1.01
The binding of chondroitin sulphate to collagen. FEBS Lett (1975) 1.01
Partial genome scale analysis of gene expression in human adipose tissue using DNA array. Obes Res (2000) 1.01
Role of the needling per se in acupuncture as prophylaxis for menstrually related migraine: a randomized placebo-controlled study. Cephalalgia (2005) 1.00
Myocardial stress perfusion scintigraphy with rubidium-81 versus stress electrocardiography. Am J Cardiol (1977) 1.00
Neuropeptide Y (NPY): enhancement of blood pressure increase upon alpha-adrenoceptor activation and direct pressor effects in pithed rats. Eur J Pharmacol (1985) 1.00
Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone. Acta Physiol Scand (1985) 1.00
Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo. Scand J Gastroenterol Suppl (1985) 1.00
Changes of visual function and visual ability in daily life following cataract surgery. Acta Ophthalmol Scand (1996) 0.99
Growth failure, encephalopathy, and endocrine dysfunctions in two siblings, one with 5-oxoprolinase deficiency. Eur J Pediatr (1997) 0.99
Prolactin (PRL) receptor gene expression in mouse adipose tissue: increases during lactation and in PRL-transgenic mice. Endocrinology (2000) 0.98
Appearance of secretory IgM and IgA antibodies to Escherichia coli in saliva during early infancy and childhood. J Pediatr (1984) 0.98
Birth weight, adulthood BMI, and subsequent weight gain in relation to leptin levels in Swedish women. Obes Res (1999) 0.98
Increased noradrenaline release in rat portal vein during sympathetic nerve stimulation due to activation of presynaptic beta-adrenoceptors by noradrenaline and adrenaline. Eur J Pharmacol (1978) 0.98
Cyclical variations in the abundance of leptin receptors, but not in circulating leptin, correlate with NPY expression during the oestrous cycle. Neuroendocrinology (1999) 0.97
Cancer chemotherapy in advanced malignant disease. A cost benefit analysis. Acta Radiol Oncol Radiat Phys Biol (1979) 0.97
Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat. Gastroenterology (1991) 0.97
Methotrexate treatment for retained placental tissue. Eur J Obstet Gynecol Reprod Biol (1999) 0.97
Secretory IgA antibody response against Escherichia coli antigens in infants in relation to exposure. J Pediatr (1985) 0.95
Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach. Regul Pept (1989) 0.95
Systemic absorption of adrenaline after aerosol, eye-drop and subcutaneous administration to healthy volunteers. Allergy (1987) 0.95